Combined pituitary hormone deficiency due to gross deletions in the POU1F1 (PIT-1) and PROP1 genes
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu kazuistiky, časopisecké články
PubMed
28356564
PubMed Central
PMC5537413
DOI
10.1038/jhg.2017.34
PII: jhg201734
Knihovny.cz E-zdroje
- MeSH
- dítě MeSH
- dospělí MeSH
- haplotypy * MeSH
- homeodoménové proteiny genetika MeSH
- hypopituitarismus genetika MeSH
- lidé MeSH
- mladiství MeSH
- předškolní dítě MeSH
- rodokmen MeSH
- sekvenční delece * MeSH
- transkripční faktor Pit-1 genetika MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- Názvy látek
- homeodoménové proteiny MeSH
- POU1F1 protein, human MeSH Prohlížeč
- Prophet of Pit-1 protein MeSH Prohlížeč
- transkripční faktor Pit-1 MeSH
Pituitary development depends on a complex cascade of interacting transcription factors and signaling molecules. Lesions in this cascade lead to isolated or combined pituitary hormone deficiency (CPHD). The aim of this study was to identify copy number variants (CNVs) in genes known to cause CPHD and to determine their structure. We analyzed 70 CPHD patients from 64 families. Deletions were found in three Turkish families and one family from northern Iraq. In one family we identified a 4.96 kb deletion that comprises the first two exons of POU1F1. In three families a homozygous 15.9 kb deletion including complete PROP1 was discovered. Breakpoints map within highly homologous AluY sequences. Haplotype analysis revealed a shared haplotype of 350 kb among PROP1 deletion carriers. For the first time we were able to assign the boundaries of a previously reported PROP1 deletion. This gross deletion shows strong evidence to originate from a common ancestor in patients with Kurdish descent. No CNVs within LHX3, LHX4, HESX1, GH1 and GHRHR were found. Our data prove multiplex ligation-dependent probe amplification to be a valuable tool for the detection of CNVs as cause of pituitary insufficiencies and should be considered as an analytical method particularly in Kurdish patients.
Department of Endocrinology Ataturk Training and Research Hospital Izmir Turkey
Department of Endocrinology Dicle University Diyarbakir Turkey
Department of Pediatrics Leiden University Medical Center Leiden The Netherlands
PAN Institute for Endocrinology and Reproductive Medicine Cologne Germany
Zobrazit více v PubMed
Tanriverdi, F., Dokmetas, H. S., Kilicli, F., Atmaca, H., Yarman, S., Ertorer, M. E. et al. Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from pituitary study group database. Endocrine 47, 198–205 (2014). PubMed
Cogan, J. D., Wu, W., Phillips, J. A., Arnhold, I. J., Agapito, A., Fofanova, O. V. et al. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 83, 3346–3349 (1998). PubMed
Vieira, T. C., Boldarine, V. T. & Abucham, J. Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency. Arq. Bras. Endocrinol. Metabol. 51, 1097–1103 (2007). PubMed
Reynaud, R., Gueydan, M., Saveanu, A., Vallette-Kasic, S., Enjalbert, A., Brue, T. et al. Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J. Clin. Endocrinol. Metab. 91, 3329–3336 (2006). PubMed
Pfäffle, R. & Klammt, J. Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. Best Pract. Res. Clin. Endocrinol. Metab. 25, 43–60 (2011). PubMed
Mccabe, M. J., Alatzoglou, K. S. & Dattani, M. T. Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond. Best Pract. Res. Clin. Endocrinol. Metab. 25, 115–124 (2011). PubMed
Gregory, L. C., Humayun, K. N., Turton, J. P. G., Mccabe, M. J., Rhodes, S. J. & Dattani, M. T. Novel lethal form of congenital hypopituitarism associated with the first recessive LHX4 mutation. J. Clin. Endocrinol. Metab. 100, 2158–2164 (2015). PubMed PMC
Sornson, M., Wu, W., Dasen, J., Flynn, S., Norman, D., O’Connell, S. et al. Pituitary lineage determination by the prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327–333 (1996). PubMed
Böttner, A., Keller, E., Kratzsch, J., Stobbe, H., Weigel, J. F. W., Keller, A. et al. PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J. Clin. Endocrinol. Metab. 89, 5256–5265 (2004). PubMed
Lebl, J., Vosáhlo, J., Pfaeffle, R. W., Stobbe, H., Cerná, J., Novotná, D. et al. Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects. Eur. J. Endocrinol. 153, 389–396 (2005). PubMed
Fofanova, O., Takamura, N., Kinoshita, E., Vorontsov, A., Vladimirova, V., Dedov, I. et al. MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. AJR Am. J. Roentgenol. 174, 555–559 (2000). PubMed
Voutetakis, A., Argyropoulou, M., Sertedaki, A., Livadas, S., Xekouki, P., Maniati-Christidi, M. et al. Pituitary magnetic resonance imaging in 15 patients with PubMed
Obermannova, B., Pfaeffle, R., Zygmunt-Gorska, A., Starzyk, J., Verkauskiene, R., Smetanina, N. et al. Mutations and pituitary morphology in a series of 82 patients with PubMed
Mendonca, B. B., Osorio, M. G., Latronico, A. C., Estefan, V., Lo, L. S. & Arnhold, I. J. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PubMed
Kandemir, N., Vurallı, D., Taşkıran, E., Gönç, N. & Özön, A. Frequency of mutations in PubMed
Abrão, M. G., Leite, M. V., Carvalho, L. R., Billerbeck, A. E. C., Nishi, M. Y., Barbosa, A. S. et al. Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clin. Endocrinol. (Oxf) 65, 294–300 (2006). PubMed
Baş, F., Uyguner, Z. O., Darendeliler, F., Aycan, Z., Cetinkaya, E., Berberoğlu, M. et al. Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study. Endocrine 49, 479–491 (2015). PubMed
Hemchand, K., Anuradha, K., Neeti, S., Vaman, K., Pfäffle, R., Blum, W. et al. Entire prophet of PubMed
Kelberman, D., Turton, J. P. G., Woods, K. S., Mehta, A., Al-Khawari, M., Greening, J. et al. Molecular analysis of novel PROP1 mutations associated with combined pituitary hormone deficiency (CPHD). Clin. Endocrinol. (Oxf) 70, 96–103 (2009). PubMed
Zhang, H., Wang, Y., Han, L., Gu, X. & Shi, D. A large deletion of PubMed
Akcay, A., Ulucan, K., Taskin, N., Boyraz, M., Akcay, T., Zurita, O. et al. Suprasellar mass mimicking a hypothalamic glioma in a patient with a complete PROP1 deletion. Eur. J. Med. Genet. 56, 445–451 (2013). PubMed
Li, S., Crenshaw, E., Rawson, E., Simmons, D., Swanson, L. & Rosenfeld, M. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene PubMed
Pfäffle, R. W., DiMattia, G. E., Parks, J. S., Brown, M. R., Wit, J. M., Jansen, M. et al. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257, 1118–1121 (1992). PubMed
Pellegrini-Bouiller, I., Belicar, P., Barlier, A., Gunz, G., Charvet, J. P., Jaquet, P. et al. A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 81, 2790–2796 (1996). PubMed
Turton, J. P. G., Reynaud, R., Mehta, A., Torpiano, J., Saveanu, A., Woods, K. S. et al. Novel mutations within the PubMed
Salemi, S., Besson, A., Eblé, A., Gallati, S., Pfäffle, R. W. & Mullis, P. E. New N-terminal located mutation (Q4ter) within the PubMed
Gat-Yablonski, G., Frumkin-Ben David, R., Bar, M., Potievsky, O., Phillip, M. & Lazar, L. Homozygous microdeletion of the PubMed
Alatzoglou, K. S. & Dattani, M. T. Genetic causes and treatment of isolated growth hormone deficiency—an update. Nat. Rev. Endocrinol. 6, 562–576 (2010). PubMed
Dusatkova, P., Pfäffle, R., Brown, M., Akulevich, N., Arnhold, I., Kalina, M. et al. Genesis of two most prevalent PubMed PMC
De Rienzo, F., Mellone, S., Bellone, S., Babu, D., Fusco, I., Prodam, F. et al. Frequency of genetic defects in combined pituitary hormone deficiency: a systematic review and analysis of a multicentre Italian cohort. Clin. Endocrinol. (Oxf) 83, 849–860 (2015). PubMed
McLennan, K., Jeske, Y., Cotterill, A., Cowley, D., Penfold, J., Jones, T. et al. Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates. Clin. Endocrinol. (Oxf) 58, 785–794 (2003). PubMed
de Graaff, L. C. G., Argente, J., Veenma, D. C. M., Drent, M. L., Uitterlinden, A. G. & Hokken-Koelega, A. C. S. PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency. Horm. Res. Paediatr. 73, 363–371 (2010). PubMed
Rainbow, L. A., Rees, S. A., Shaikh, M. G., Shaw, N. J., Cole, T., Barrett, T. G. et al. Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. Clin. Endocrinol. (Oxf) 62, 163–168 (2005). PubMed
Navardauskaite, R., Dusatkova, P., Obermannova, B., Pfaeffle, R. W., Blum, W. F., Adukauskiene, D. et al. High prevalence of PROP1 defects in Lithuania: phenotypic findings in an ethnically homogenous cohort of patients with multiple pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 99, 299–306 (2014). PubMed
Deininger, P. L. & Batzer, M. A. Alu repeats and human disease. Mol. Genet. Metab. 67, 183–193 (1999). PubMed
Batzer, M. A. & Deininger, P. L. Alu repeats and human genomic diversity. Nat. Rev. Genet. 3, 370–379 (2002). PubMed
Arroyo, A., Pernasetti, F., Vasilyev, V. V., Amato, P., Yen, S. S. C. & Mellon, P. L. A unique case of combined pituitary hormone deficiency caused by a PubMed PMC
Asteria, C., Oliveira, J. H., Abucham, J. & Beck-Peccoz, P. Central hypocortisolism as part of combined pituitary hormone deficiency due to mutations of PubMed
Fofanova, O. V., Takamura, N., Kinoshita, E., Parks, J. S., Brown, M. R., Peterkova, V. A. et al. A mutational hot spot in the PubMed
Halász, Z., Toke, J., Patócs, A., Bertalan, R., Tömböl, Z., Sallai, Á. et al. High prevalence of PubMed
Lemos, M. C., Gomes, L., Bastos, M., Leite, V., Limbert, E., Carvalho, D. et al. PubMed
Pernasetti, F., Toledo, S. P., Vasilyev, V. V., Hayashida, C. Y., Cogan, J. D., Ferrari, C. et al. Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of PubMed
Tatsumi, K.-I., Kikuchi, K., Tsumura, K. & Amino, N. A novel PubMed
Vallette-Kasic, S., Barlier, A., Teinturier, C., Diaz, A., Manavela, M., Berthezène, F. et al. PubMed
Flück, C., Deladoey, J., Rutishauser, K., Eblé, A., Marti, U., Wu, W. et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PubMed